Dishman Carbogen Amcis Limited (NSE:DCAL)
150.67
+1.81 (1.22%)
Oct 29, 2026, 10:50 AM IST
Dishman Carbogen Amcis Employees
Dishman Carbogen Amcis had 934 employees as of March 31, 2026. The number of employees decreased by 172 or 15.55% compared to the previous year. That makes Dishman Carbogen Amcis the 15,417th largest employer in the world and 1,173rd in India.
Employees
934
Change (1Y)
-172
Growth (1Y)
-15.55%
Revenue / Employee
31.07M INR
Profits / Employee
173.02K INR
Market Cap
23.62B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 934 | -172 | -15.55% |
| Mar 31, 2025 | 1,106 | -26 | -2.30% |
| Mar 31, 2024 | 1,132 | -163 | -12.59% |
| Mar 31, 2023 | 1,295 | 127 | 10.87% |
| Mar 31, 2022 | 1,168 | 239 | 25.73% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Biocon | 16,447 |
| Anthem Biosciences | 2,282 |
| Panacea Biotec | 2,102 |
| OneSource Specialty Pharma | 1,674 |
| Concord Biotech | 1,624 |
| Lyka Labs | 648 |
| Zota Health Care | 635 |
| Haleos Labs | 611 |
Dishman Carbogen Amcis News
- 4 months ago - Dishman Carbogen Amcis shares rise nearly 3% on June 30 after Swiss subsidiary commissions 1.2 MW solar power plant; here's why - Business Upturn
- 1 year ago - Dishman Carbogen clears US FDA inspection at Naroda facility with no observations - Business Upturn
- 1 year ago - Dishman Carbogen shares in focus after Swiss subsidiary signs CHF 25 million co-investment agreement - Business Upturn
- 1 year ago - Dishman Carbogen Amcis shares surge over 11% as company swings to profit in Q4, EBITDA margin doubles - Business Upturn
- 1 year ago - Dishman Carbogen shares surge 5% after arm gets drug manufacturing licence In China - Business Upturn
- 1 year ago - Dishman Carbogen Amcis subsidiary receives drug manufacturing license in China - Business Upturn
- 1 year ago - Dishman Carbogen Amcis shares jump nearly 2% after board approves Rs 50 crore debenture issuance - Business Upturn
- 1 year ago - Dishman Carbogen subsidiary successfully completes Swissmedic inspection of its Vionnaz facility - Business Upturn